4.4 Review

Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition beyond low-density lipoprotein cholesterol

期刊

AMERICAN JOURNAL OF CARDIOLOGY
卷 96, 期 5A, 页码 24F-33F

出版社

EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjcard.2005.06.009

关键词

-

资金

  1. NHLBI NIH HHS [HL-52233, R01 HL070274, R01 HL052233, R01 HL052233-06, R01 HL052233-07, R01 HL070274-01, R01 HL052233-05, R01 HL070274-02] Funding Source: Medline
  2. NIDDK NIH HHS [R01 DK062729, R01 DK062729-01A1, R01 DK062729-02] Funding Source: Medline
  3. NINDS NIH HHS [P01 NS010828-330036, P50 NS010828, P01 NS010828, F32 NS010828, NS-10828, P50 NS010828-290036] Funding Source: Medline

向作者/读者索取更多资源

Statins are potent inhibitors of cholesterol biosynthesis and exert beneficial effects in the primary and secondary prevention of coronary artery disease. However, the overall benefits observed with statins appear to occur much earlier and to be greater than what might be expected from changes in lipid levels alone, suggesting effects beyond cholesterol lowering. Indeed, recent studies indicate that some of the cholesterol-independent or pleiotropic effects of statins involve improving endothelial function, enhancing the stability of atherosclerotic plaques, decreasing oxidative stress and inflammation, and inhibiting the thrombogenic response. Many of these pleiotropic effects are mediated by inhibition of isoprenoids, which serve as lipid attachments for intracellular signaling molecules. In particular, inhibition of the small guanosine triphosphate-binding proteins Rho, Ras, and Rac, whose proper membrane localization and function are dependent on isoprenylation, may play an important role in mediating the pleiotropic effects of statins. (c) 2005 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据